Atmofizer Technologies Inc. Files Financial Statements and MD&A
VANCOUVER, BC, January 28, 2022 /PRNewswire/ – Atmofizer Technologies Inc. (formerly Consolidated HCI Holdings Corporation) (the “Society” Where “atmovisor“) (CSE: ATMO) (Frankfurt: J3K) announced that it had filed its audited financial statements, related management report and annual information form for the year ended September 30, 2021.
The year ended September 30, 2021 represented the Company’s last annual fiscal year prior to the completion of its reverse takeover transaction with Vaxxinator Enterprises Inc., the completion of which was announced on November 15, 2021 (the “Reverse takeoverThe Company has not conducted any transactions prior to the completion of the Reverse Takeover other than the identification and evaluation of businesses or assets with a view to the completion of a Reverse Takeover.
The Company and Steinbrenner Racing, LLC (“Steinbrenner race“) amended the terms of their sponsorship agreement granting Atmofizer the right to sponsor an IndyCar and the team’s driver. The amendments provide additional sponsorship rights, including becoming the official supplier sponsor of an IndyCar car. Team Steinbrenner Racing for the “24 Hours of Daytona” race to be held in 2022 and 2023. In addition, Steinbrenner Racing will facilitate business introductions to stadium and arena owners and operators and assist with product testing and development. In consideration for the Amendments, the Company issued 4,500,000 common shares in the Company’s authorized shareholding structure (“Ordinary actions“) at a deemed price of $0.26 per share to Steinbrenner Racing. The common shares issued to Steinbrenner Racing are subject to a statutory hold period which will expire four months and one day from the date of issue in accordance with applicable Canadian securities laws.
“We are delighted to extend our commercial relationship with Steinbrenner Racing, with the hosting of the 2022 edition of the 24 Hours of Daytona saturday 29 january, 2022, to promote our brand and technology,” said Atmofizer CEO, Oliver Centner. “Steinbrenner Racing will also work collaboratively with us in this expanded business relationship to help bring our business to major US stadiums and sporting venues where clean air is a key goal. Additionally, we are excited to work with Steinbrenner Racing in application of our technology in the automotive industry to improve air quality.”
Atmofizer has also entered into a debt settlement agreement (“debt settlement agreement“) with an arm’s length business development and media consultant, for debt in the aggregate amount of US$396,730, an alleged value of $500,000 (the “Debt“). To settle the debt, the Company issued an aggregate of 2,000,000 common shares at a deemed price of $0.26 per share, pursuant to the terms and subject to the conditions of the Settlement Agreement. debt The issued common shares are subject to a statutory hold period which will expire four months and one day from the date of issuance in accordance with applicable Canadian securities laws.
About Atmofizer Technologies Inc.
Atmofizer’s consumer and industrial solutions are based on its patented ultrafine particle agglomeration and neutralization technology. This capability creates a revolutionary and more efficient method of dealing with the wide range of dangerous nanoparticles, viruses and bacteria that are too small to be effectively handled by conventional HEPA filters and ultraviolet lamps. Atmofizer plans to disrupt the air treatment industry by improving air safety and purification efficiency while reducing operating costs for customers.
Atmofiizing air refers to the process of using ultrasonic sound waves to agglomerate (cluster) small particles into a larger target which is then irradiated with ultraviolet light to neutralize their harmful properties, making the air you breathe less dangerous to your health. Using units that atmofize the air in tandem with HEPA filters can make HEPA filters more efficient, allow the use of a less powerful filter, and result in a cleaner, longer lasting filter that reduces operating costs. operation and poses fewer health risks. clean or replace.
Atmofizer is the only source of patent-pending, patent-protected technology to atmofize air and applies its proprietary technology in consumer and industrial air purification products currently manufactured under the Atmofizer brand, as well as in retail and commercial devices produced by other companies that incorporate Atmofizer technology into their own licensed products. Atmofizer’s owned and licensed product lines include portable, portable and mobile use for personal air handling, as well as larger systems to handle higher air volumes for commercial, industrial, institutional and residential.
This press release contains “forward-looking information” within the meaning of applicable securities laws. Any statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some instances, forward-looking information may be identified by words or phrases such as “may”, “will”, “expect”, “probable”, “should”, “would”, “expect”, ” anticipates”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative form of these terms, or other similar words, phrases and grammatical variations, or statements that certain events or conditions “can” or “will” happen, or through policy discussions. Forward-looking information contained herein includes, but is not limited to, the Company’s partnership with Steinbrenner Racing, as well as the Company’s business and strategic plans.
By its nature, forward-looking information is subject to inherent risks and uncertainties which may be general or specific and which give rise to the possibility that the expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that the assumptions are not correct and that the objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information contained in this press release, including, without limitation: the ability to the Company to comply with all applicable laws and governmental regulations relating to its commercial products; the Company’s ability to protect its intellectual property; impacts on the Company’s business and operations due to the COVID-19 pandemic; having only a limited operating history, the Company’s ability to access capital to meet its future financing needs; the Company’s dependence on management and key personnel; competetion; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.
Other risk factors can also be found in the Company’s continuous disclosure documents, which have been filed on SEDAR and can be viewed at www.sedar.com. Readers are cautioned to carefully consider these factors, as well as other factors, uncertainties and potential events, and not to place undue reliance on any forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management as of the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise, or to explain any material differences between subsequent actual events and such forward-looking information, except as required by applicable law.
SOURCEAtmofizer Technologies Inc.